ARCTURUS THERAPEUTICS LTD's ticker is ARCT and the CUSIP is M1492T105. A total of 1 filers reported holding ARCTURUS THERAPEUTICS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,000 | – | 250 | +101.6% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 124 | -95.6% | 0.00% | – |
| Q3 2018 | $24,000 | 0.0% | 2,795 | -4.0% | 0.00% | – |
| Q2 2018 | $24,000 | +242.9% | 2,910 | +100.7% | 0.00% | – |
| Q1 2018 | $7,000 | -58.8% | 1,450 | -35.2% | 0.00% | -100.0% |
| Q4 2017 | $17,000 | – | 2,239 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 32,848 | $290,000 | 0.22% |
| ARK Investment Management | 773,772 | $6,840,000 | 0.21% |
| ROYCE & ASSOCIATES LP | 106,436 | $941,000 | 0.01% |
| Independence Bank of Kentucky | 607 | $5,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 18,700 | $164,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 27,300 | $241,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 4,086 | $36,000 | 0.00% |
| 1832 Asset Management L.P. | 560 | $5,000 | 0.00% |
| CITIGROUP INC | 171 | $2,000 | 0.00% |
| MORGAN STANLEY | 47,965 | $424,000 | 0.00% |